Kraig Biocraft Laboratories (KBLB) Amortization of Deferred Charges (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Amortization of Deferred Charges across 6 years of filings, most recently posting $18803.0 for Q4 2025.

• Amortization of Deferred Charges for Q4 2025 came in at $18803.0, down 7.73% year-over-year; the trailing twelve-month figure through Dec 2025 was $79497.0 (down 1.94% YoY), and the FY2025 annual result was $79275.0, down 2.22% from the prior year.
• Amortization of Deferred Charges came in at $18803.0 for Q4 2025 at Kraig Biocraft Laboratories, down from $20379.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $2.1 million in Q3 2021 to a low of $18803.0 in Q4 2025.
• The 5-year median for Amortization of Deferred Charges is $20379.0 (2023), against an average of $317683.3.
• Across the five-year window, Amortization of Deferred Charges soared 53.73% in 2022 and plunged 94.89% in 2023, its largest moves.
• Kraig Biocraft Laboratories' Amortization of Deferred Charges stood at $529963.0 in 2021, then decreased by 24.79% to $398603.0 in 2022, then slumped by 94.89% to $20379.0 in 2023, then changed by 0.0% to $20379.0 in 2024, then slipped by 7.73% to $18803.0 in 2025.
• The last three Amortization of Deferred Charges figures came in at $18803.0 (Q4 2025), $20379.0 (Q3 2025), and $20379.0 (Q2 2025), per Business Quant data.